Style | Citing Format |
---|---|
MLA | Peyman M, et al.. "Intravitreal Bevacizumab Versus Ranibizumab: Effects on the Vessels of the Fellow Non-Treated Eye." Journal of Current Ophthalmology, vol. 31, no. 1, 2019, pp. 55-60. |
APA | Peyman M, Peyman A, Lansingh VC, Orandi A, Subrayan V (2019). Intravitreal Bevacizumab Versus Ranibizumab: Effects on the Vessels of the Fellow Non-Treated Eye. Journal of Current Ophthalmology, 31(1), 55-60. |
Chicago | Peyman M, Peyman A, Lansingh VC, Orandi A, Subrayan V. "Intravitreal Bevacizumab Versus Ranibizumab: Effects on the Vessels of the Fellow Non-Treated Eye." Journal of Current Ophthalmology 31, no. 1 (2019): 55-60. |
Harvard | Peyman M et al. (2019) 'Intravitreal Bevacizumab Versus Ranibizumab: Effects on the Vessels of the Fellow Non-Treated Eye', Journal of Current Ophthalmology, 31(1), pp. 55-60. |
Vancouver | Peyman M, Peyman A, Lansingh VC, Orandi A, Subrayan V. Intravitreal Bevacizumab Versus Ranibizumab: Effects on the Vessels of the Fellow Non-Treated Eye. Journal of Current Ophthalmology. 2019;31(1):55-60. |
BibTex | @article{ author = {Peyman M and Peyman A and Lansingh VC and Orandi A and Subrayan V}, title = {Intravitreal Bevacizumab Versus Ranibizumab: Effects on the Vessels of the Fellow Non-Treated Eye}, journal = {Journal of Current Ophthalmology}, volume = {31}, number = {1}, pages = {55-60}, year = {2019} } |
RIS | TY - JOUR AU - Peyman M AU - Peyman A AU - Lansingh VC AU - Orandi A AU - Subrayan V TI - Intravitreal Bevacizumab Versus Ranibizumab: Effects on the Vessels of the Fellow Non-Treated Eye JO - Journal of Current Ophthalmology VL - 31 IS - 1 SP - 55 EP - 60 PY - 2019 ER - |